Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 30 Dec 2003):

Sex differences in behavioral, neurochemical and neuroendocrine effects induced by the forced swim test in rats.

Full Abstract

The forced swim test (FST) has been considered as a pharmacologically valid test of the depressive syndrome in rodents. However, few studies have focused on neurochemical and behavioral responses during FST in both male and female rats. Thus, we investigated certain behavioral and neuroendocrine responses as well as the serotonergic activity after the application of FST in both sexes. Our data show that the duration of immobility was increased in both male and female rats during the 2nd session of the FST. Sex differences are observed in some behavioral responses, such as head swinging that is mostly present in male rats. In female rats FST induced a decrease in serotonergic activity in hippocampus and hypothalamus while in male rats it induced an increase in serotonergic activity in hypothalamus. Corticosterone serum levels were elevated in both sexes. However, hippocampal GR mRNA levels tended to be increased in males and females respectively. Moreover, hypothalamic serotonin (5-HT)1A mRNA levels were decreased in female rats while in male rats hippocampal 5-HT1A mRNA levels were increased. These data have shown that FST induces "depressive like symptoms" in both sexes and provide evidence that sex differences characterize certain behavioral aspects in the FST. Notably, hippocampal and hypothalamic serotonergic activity has been differentially modified in male rats compared with female rats and these neurochemical findings could be relevant to the differentiated expression of 5-HT1A receptor. Hypothalamic-pituitary-adrenal axis activity was also affected by FST application in a sex specific manner. The present results support that FST induced behavioral, neurochemical and neurobiological alterations, which are sex dependent. Copyright 2004 IBRO

 

Author information

Author/s: Drossopoulou, G (G); Antoniou, K (K); Kitraki, E (E); Papathanasiou, G (G); Papalexi, E (E); Dalla, C (C); Papadopoulou-Daifoti, Z (Z);

Affiliation: Department of Experimental Pharmacology, Medical School, University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece.

Journal and publication information

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

Journal: Neuroscience (Neuroscience), published in United States. (Language: eng)

Reference: 2004-; vol 126 (issue 4) : pp 849-57

Dates: Created 2004/06/21; Completed 2004/10/08; Revised 2006/11/15;

PMID: 15207320, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: 18 Feb 2009 00:00:00)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: RNA, Messenger (0) ; Receptor, Serotonin, 5-HT1A (112692-38-3) ; Corticosterone (50-22-6) ; Serotonin (50-67-9) ; Hydroxyindoleacetic Acid (54-16-0)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

9/29/2004
11/29/2008
Higher Relevance Score (31)
Lower Relevance Score (17)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index